- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02071771
Visual Assessment of DAILIES® AquaComfort Plus® for Astigmatism as Compared to 1-DAY ACUVUE® MOIST® for Astigmatism
October 13, 2015 updated by: Alcon Research
DAILIES® AquaComfort Plus® Toric - Comparative Assessment of Visual and Mechanical Performance
The purpose of this study is to evaluate functional vision associated with rotational stability at blink of DAILIES® AquaComfort Plus® Toric (DACP T) compared to 1-DAY ACUVUE® MOIST® for Astigmatism (1DAM A).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must sign an Informed Consent document;
- Wear toric soft contact lenses within the protocol-specified range;
- Cylinder equal or higher than -0.75 diopters (D) in both eyes;
- Have an acceptable fit with both study contact lenses;
- Willing to wear lenses for a minimum of 5 days per week, 6 hours per day, every day, if possible;
- Best corrected visual acuity (BCVA) of 20/30 Snellen;
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Any ocular infection, inflammation, abnormality, or disease that would contraindicate contact lens wear;
- Use of systemic or ocular medications that would contraindicate contact lens wear, as determined by the investigator;
- Monocular (only 1 eye with functional vision) or fit with only 1 lens;
- Require presbyopic correction;
- Any ocular condition observed during examination at the enrollment visit;
- History of herpetic keratitis, ocular surgery or irregular cornea;
- Pregnant or lactating;
- Participation in any clinical trial within 30 days of the enrollment visit;
- Currently wearing Focus® DAILIES® Toric or 1-DAY ACUVUE® MOIST® for Astigmatism;
- Other protocol-specified exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: DACP T, Then 1DAM A
Nelfilcon A toric contact lenses worn first, with etafilcon A toric contact lenses worn second.
Each product worn bilaterally on a daily wear, daily disposable basis for 10 days.
|
Other Names:
Other Names:
|
|
Other: 1DAM A, Then DACP T
Etafilcon A toric contact lenses worn first, with nelfilcon A toric contact lenses worn second.
Each product worn bilaterally on a daily wear, daily disposable basis for 10 days.
|
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
High Contrast Time Controlled Visual Acuity (TCVA) at Day 10
Time Frame: Day 10, each product
|
TCVA test was performed at 4 meters under high illumination (90%) using a Landolt ring test.
For each acuity level, a series of single rings with gaps in one of four directions was presented and the percentage of correctly identified rings constituted the score.
TCVA was measured in VA units and a higher TCVA value indicates an improvement in visual acuity.
Both eyes contributed to the analysis.
|
Day 10, each product
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Oscillation at Blink at Day 10
Time Frame: Day 10, each product
|
Lens oscillation (rotational stability of the lens on the eye) at blink was video-recorded.
Digital images were used to measure the rotational characteristics of the lenses and objectively measure the amplitude of the lens oscillation.
A higher value indicates greater lens movement on the eye.
This outcome measure was collected at one site only.
|
Day 10, each product
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Clinical Manager, EMEA, Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
February 24, 2014
First Submitted That Met QC Criteria
February 24, 2014
First Posted (Estimate)
February 26, 2014
Study Record Updates
Last Update Posted (Estimate)
November 10, 2015
Last Update Submitted That Met QC Criteria
October 13, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-14-007
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ohio State UniversityAlcon ResearchCompletedAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
Clinical Trials on Nelfilcon A toric contact lenses
-
CIBA VISIONCompletedRefractive Error | Astigmatism | Myopia
-
Alcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompletedRefractive Error | Presbyopia
-
CooperVision, Inc.Completed
-
CIBA VISIONCompletedAstigmatism | Myopia
-
Alcon ResearchCompletedRefractive Errors | AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive ErrorsUnited Kingdom
-
Alcon ResearchCompletedAstigmatism | Myopia | AmetropiaUnited States